Veracyte, Inc., a leading cancer diagnostics company, has officially presented new data at the 2025 ASCO Genitourinary Cancers Symposium (ASCO GU), data which is...
Veracyte, Inc., a leading cancer diagnostics company, has officially presented new data at the 2025 ASCO Genitourinary Cancers Symposium (ASCO GU), data which is...
The researching team at Children's Hospital of Philadelphia (CHOP) has officially announced the creation of a new AI technology called CelloType, which happens to...
Harbinger Health, a biotechnology company pioneering new technologies to fundamentally change cancer screening and detection, has officially announced the launch of three abstracts that...
